WDR82 is relatively high in glioma vs. other cancers (Supplementary Figure S4), which is the sole subunit in SETD1A-COMPASS, specifically associated with pediatric glioma WHO-grade malignancy (Figure 2A) and patient survival (Figure 2D), regardless of histone mutation status. This evidence concerns the gene SETD1A and central nervous system cancer.